EP 1613766 A1 20060111 - SGK1 AS DIAGNOSTIC AND THERAPEUTIC TARGET
Title (en)
SGK1 AS DIAGNOSTIC AND THERAPEUTIC TARGET
Title (de)
SGK1 ALS DIAGNOSTISCHES UND THERAPEUTISCHES TARGET
Title (fr)
SGK1 SERVANT DE CIBLE DIAGNOSTIQUE ET THERAPEUTIQUE
Publication
Application
Priority
EP 0302163 W 20030303
Abstract (en)
[origin: WO2004079003A1] The invention relates to the utilization of a substance for diagnostic determination of sgk1 (serum and glucocorticoid dependent kinase 1) and to the utilization of an active agent in order to influence sgk1 for therapeutic treatment of diseases associated with disordered activity of the tissue factor and to a diagnostic kit related thereto.
IPC 1-7
IPC 8 full level
C12Q 1/48 (2006.01)
CPC (source: EP KR US)
A61K 31/435 (2013.01 - KR); A61P 3/10 (2017.12 - EP); A61P 7/04 (2017.12 - EP); A61P 9/00 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 9/12 (2017.12 - EP); A61P 17/02 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 37/00 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C12Q 1/485 (2013.01 - EP KR US); G01N 33/5302 (2013.01 - KR)
Citation (search report)
See references of WO 2004079003A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2004079003 A1 20040916; AU 2003215623 A1 20040928; AU 2003215623 B2 20091022; BR 0318166 A 20060404; CA 2517958 A1 20040916; CN 100529101 C 20090819; CN 1771330 A 20060510; EP 1613766 A1 20060111; JP 2006518992 A 20060824; JP 4762552 B2 20110831; KR 101032281 B1 20110506; KR 20060015467 A 20060217; KR 20110005747 A 20110118; MX PA05009292 A 20060321; US 2007059695 A1 20070315; US 2012149765 A1 20120614
DOCDB simple family (application)
EP 0302163 W 20030303; AU 2003215623 A 20030303; BR 0318166 A 20030303; CA 2517958 A 20030303; CN 03826398 A 20030303; EP 03816137 A 20030303; JP 2004569000 A 20030303; KR 20057016434 A 20030303; KR 20107029753 A 20030303; MX PA05009292 A 20030303; US 201113315850 A 20111209; US 54774603 A 20030305